Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||
| Net Income | -6,883 | -6,362 | -10,238 |
| Depreciation Amortization | 7,203 | 5,131 | 777 |
| Accounts receivable | -1,365 | -2,116 | N/A |
| Other Working Capital | -2,166 | -3,019 | 514 |
| Other Operating Activity | 1,575 | 2,230 | 277 |
| Operating Cash Flow | $-1,636 | $-4,136 | $-8,669 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -50,294 | N/A | N/A |
| PPE Investments | -20,632 | -2,280 | -2,007 |
| Net Acquisitions | -15,000 | N/A | N/A |
| Other Investing Activity | -2,960 | 91 | -98 |
| Investing Cash Flow | $-88,886 | $-2,189 | $-2,105 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | N/A | 375 |
| Debt Repayment | -540 | -516 | -116 |
| Common Stock Issued | 123,326 | 115,410 | 29 |
| Other Financing Activity | 0 | 30,442 | 15,695 |
| Financing Cash Flow | $122,786 | $145,337 | $15,982 |
| Beginning Cash Position | 144,413 | 5,402 | 194 |
| End Cash Position | 176,677 | 144,413 | 5,402 |
| Net Cash Flow | $32,264 | $139,012 | $5,207 |
| Free Cash Flow | |||
| Operating Cash Flow | -1,636 | -4,136 | -8,669 |
| Capital Expenditure | -20,632 | -2,280 | -2,007 |
| Free Cash Flow | -22,268 | -6,416 | -10,676 |